Kevin D. Brandt - Aug 15, 2024 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Chief Commercial Officer
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
XTNT
Transactions as of
Aug 15, 2024
Transactions value $
-$33,800
Form type
4
Date filed
8/19/2024, 04:26 PM
Previous filing
Apr 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Tax liability -$33.8K -56.3K -5.63% $0.60 944K Aug 15, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kevin D. Brandt is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
F2 Includes an aggregate of 274,584 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 245,568 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.